Kristin Abate - 03 Sep 2025 Form 4 Insider Report for Karyopharm Therapeutics Inc. (KPTI)

Role
Chief Accounting Officer
Signature
/s/ Nancy Smith as Attorney-in-Fact for Kristin Abate
Issuer symbol
KPTI
Transactions as of
03 Sep 2025
Net transactions value
-$81.36
Form type
4
Filing time
04 Sep 2025, 16:53:21 UTC
Previous filing
23 Jul 2025
Next filing
16 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Abate Kristin Chief Accounting Officer C/O KARYOPHARM THERAPEUTICS INC., 85 WELLS AVENUE, NEWTON /s/ Nancy Smith as Attorney-in-Fact for Kristin Abate 04 Sep 2025 0002045943

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KPTI Common Stock Sale $81.36 -12 -0.13% $6.78 9,463 03 Sep 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on May 27, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person.